Australia markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4947+0.0002 (+0.04%)
At close: 04:00PM EDT
0.4900 -0.00 (-0.95%)
Pre-market: 07:35AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
221,755
113,006
161,160
260,629
-
Other short-term investments
0
67,321
138,343
419,599
-
Total cash
221,755
180,327
299,503
680,228
-
Net receivables
22,211
14,627
11,389
3,872
-
Inventory
22,919
0
-
10,698
-
Total current assets
281,685
203,572
336,520
1,215,537
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
308,859
329,032
121,644
103,077
-
Accumulated depreciation
-41,810
-30,511
-20,406
-18,141
-
Net property, plant and equipment
267,049
298,521
101,238
84,936
-
Equity and other investments
0
1,414
97,114
61,445
-
Goodwill
5,646
5,646
5,646
5,646
-
Intangible assets
10,438
4,868
-
4,397
14,326
Other long-term assets
54,343
55,793
53,277
409,291
-
Total non-current assets
337,476
366,242
257,275
565,715
-
Total assets
619,161
569,814
593,795
1,781,252
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
18,498
14,867
25,883
13,811
-
Accrued liabilities
38,815
25,004
59,429
53,071
-
Deferred revenues
-
1,502
2,282
1,500
18,854
Other current liabilities
9,036
8,365
1,152
84,303
-
Total current liabilities
200,113
156,579
152,993
203,588
-
Non-current liabilities
Deferred revenues
-
-
-
47,343
37,625
Other long-term liabilities
92
92
93
5,759
-
Total non-current liabilities
224,511
278,902
66,525
222,608
-
Total liabilities
424,624
435,481
219,518
426,196
-
Stockholders' equity
Common stock
1,905
830
711
665
-
Retained earnings
-4,260,328
-4,048,415
-3,719,925
-2,900,547
-
Accumulated other comprehensive income
-1,796
-4,070
-2,911
-5,505
-
Total stockholders' equity
194,537
134,333
374,277
1,355,056
-
Total liabilities and stockholders' equity
619,161
569,814
593,795
1,781,252
-